ask="2.7500"
ask_size="100"
average_daily_volume="297785"
bid="1.8200"
bid_size="1500"
book_value="0.7310"
change="-0.0001"
change_from_200_day_moving_average="0.9248"
change_from_50_day_moving_average="0.5609"
change_from_52_week_high="-0.1101"
change_From_52_week_low="1.3399"
change_in_percent="-0.0038%"
close="2.6399"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.4680"
ebitda="-18.07M"
eps_estimate_current_year="-0.5500"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.6200"
ex_dividend_date="N/A"
float_shares="32403000"
high="2.7500"
high_52_weeks="2.7500"
last_trade_date="3/7/2017"
last_trade_price="2.6399"
last_trade_size="100"
last_trade_time="3:59pm"
low="2.5100"
low_52_weeks="1.3000"
market_capitalization="113.67M"
moving_average_200_day="1.7151"
moving_average_50_day="2.0790"
name="Pieris Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="9.0000"
open="2.6000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+53.9246%"
percent_change_from_50_day_moving_average="+26.9812%"
percent_change_from_52_week_high="-4.0036%"
percent_change_from_52_week_low="+103.0692%"
previous_close="2.6400"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.6115"
price_per_sales="21.6769"
revenue="5.24M"
shares_outstanding="43058000"
short_ratio="1.8700"
stock_exchange="NCM"
symbol="PIRS"
volume="1157962"
weeks_range_52="1.3000 - 2.7500"
